Naturally occurring drug resistance associated variants to hepatitis C virus direct-acting antiviral agents in treatment-naive HCV genotype 1b-infected patients in China

The direct-acting antiviral agents (DAAs) have drastically improved the prognosis of hepatitis C virus (HCV) patients. However, the resistance-associated variants (RAVs) to DAAs may hamper treatment. There was a lack of data on the prevalence of pre-exist RAVs in Chinese HCV-infected patients. We pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhanyi, Zhang, Ying, Liu, Ying, Shao, Xiaoqiong, Luo, QiuMin, Cai, Qingxian, Zhao, Zhixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428597/
https://www.ncbi.nlm.nih.gov/pubmed/28489763
http://dx.doi.org/10.1097/MD.0000000000006830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428597/
https://www.ncbi.nlm.nih.gov/pubmed/28489763
http://dx.doi.org/10.1097/MD.0000000000006830

Ejemplares similares